Protagonist Therapeutics Ownership & Insider Activity

Protagonist Therapeutics Inc

PTGXNASDAQ

$138.43

-1.10-0.79%

마지막 업데이트: Oct 23, 4:35 PM

Protagonist Therapeutics Ownership & Insider Activity - Benzinga

Protagonist Therapeutics (PTGX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Net Insider Activity by Month

Date	Insider	Title	Type	Shares	Price	Value
Sep 30, 2026	Asif Ali	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$82.75	$6.9M
Sep 8, 2026	Dinesh V. Patel, Ph.D.	PRESIDENT AND CEO	SELL-OPTIONS	—	$83.75	$15.5M
Aug 10, 2026	Dinesh V. Patel, Ph.D.	PRESIDENT AND CEO	SELL-OPTIONS	—	$85.24	$12.7M
Jun 23, 2026	William D Waddill	DIRECTOR	SELL-OPTIONS	—	$67.24	$913K
Jun 10, 2026	William D Waddill	DIRECTOR	SELL-OPTIONS	—	$61.32	$834K
May 29, 2026	William D Waddill	DIRECTOR	SELL-OPTIONS	—	$55.72	$791K
May 12, 2026	Dinesh V. Patel, Ph.D.	PRESIDENT AND CEO	SELL-OPTIONS	—	$60.85	$5.9M
May 7, 2026	Bryan Giraudo	DIRECTOR	SELL	23.130K	$53.36	$5.7M